Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium

JS. Israel, LM. Marcelin, C. Thomas, E. Szczyrbová, S. Fuessel, M. Puhr, J. Linxweiler, S. Yalala, WT. Zwart, A. Baniahmad, J. van Goubergen, HM. Itkonen, A. Sharp, E. O'Neill, M. Pretze, M. Miederer, HHH. Erb

. 2024 ; 43 (1) : 194. [pub] 20240717

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kongresy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019728

Continued exploration of the androgen receptor (AR) is crucial, as it plays pivotal roles in diverse diseases such as prostate cancer (PCa), serving as a significant therapeutic focus. Therefore, the Department of Urology Dresden hosted an international meeting for scientists and clinical oncologists to discuss the newest advances in AR research. The 2nd International Androgen Receptor Symposium was held in Dresden, Saxony, Germany, from 26-27.04.2024, organised by Dr. Holger H.H. Erb. Following the format of the first meeting, more than 35 scientists from 8 countries attended the event to discuss recent developments, research challenges, and identification of venues in AR research. An important new feature was the involvement of PhD students and young investigators, acknowledging the high scientific quality of their work. The symposium included three covers: new advances from clinical research, basic and translational research, and novel strategies to target AR. Moreover, based on its increasing clinical relevance, a PSMA theranostic mini-symposium was added at the end of the AR symposium to allow the audience to discuss the newest advances in PSMA theranostic. This report focuses on the highlights and discussions of the meeting.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019728
003      
CZ-PrNML
005      
20241024110653.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13046-024-03125-5 $2 doi
035    __
$a (PubMed)39014480
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Israel, Justus Simon $u Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
245    10
$a Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium / $c JS. Israel, LM. Marcelin, C. Thomas, E. Szczyrbová, S. Fuessel, M. Puhr, J. Linxweiler, S. Yalala, WT. Zwart, A. Baniahmad, J. van Goubergen, HM. Itkonen, A. Sharp, E. O'Neill, M. Pretze, M. Miederer, HHH. Erb
520    9_
$a Continued exploration of the androgen receptor (AR) is crucial, as it plays pivotal roles in diverse diseases such as prostate cancer (PCa), serving as a significant therapeutic focus. Therefore, the Department of Urology Dresden hosted an international meeting for scientists and clinical oncologists to discuss the newest advances in AR research. The 2nd International Androgen Receptor Symposium was held in Dresden, Saxony, Germany, from 26-27.04.2024, organised by Dr. Holger H.H. Erb. Following the format of the first meeting, more than 35 scientists from 8 countries attended the event to discuss recent developments, research challenges, and identification of venues in AR research. An important new feature was the involvement of PhD students and young investigators, acknowledging the high scientific quality of their work. The symposium included three covers: new advances from clinical research, basic and translational research, and novel strategies to target AR. Moreover, based on its increasing clinical relevance, a PSMA theranostic mini-symposium was added at the end of the AR symposium to allow the audience to discuss the newest advances in PSMA theranostic. This report focuses on the highlights and discussions of the meeting.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a nádory prostaty $x metabolismus $x terapie $x genetika $7 D011471
650    12
$a androgenní receptory $x metabolismus $x genetika $7 D011944
655    _2
$a kongresy $7 D016423
700    1_
$a Marcelin, Laura-Maria $u Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
700    1_
$a Thomas, Christian $u Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
700    1_
$a Szczyrbová, Eva $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, 779 00, Czech Republic
700    1_
$a Fuessel, Susanne $u Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany $u German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Puhr, Martin $u Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
700    1_
$a Linxweiler, Johannes $u Department of Urology, Saarland University, Homburg/Saar, Germany
700    1_
$a Yalala, Shivani $u Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
700    1_
$a Zwart, Wilbert T $u Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands
700    1_
$a Baniahmad, Aria $u Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany
700    1_
$a van Goubergen, Jasper $u Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
700    1_
$a Itkonen, Harri M $u Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
700    1_
$a Sharp, Adam $u Institute of Cancer Research, Sutton, Surrey, UK
700    1_
$a O'Neill, Edward $u MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK
700    1_
$a Pretze, Marc $u Institut für Radiopharmazie, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, D-01328, Dresden, Germany
700    1_
$a Miederer, Matthias $u Department of Translational Imaging in Oncology, National Center for Tumor Diseases (NCT/UCC) Dresden: Faculty of Medicine and University Hospital Carl Gustav Carus, University of Technology Dresden (TUD), German Cancer Research Center (DKFZ) Heidelberg, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany
700    1_
$a Erb, Holger H H $u Department of Urology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. holger.erb@uniklinikum-dresden.de $u Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany. holger.erb@uniklinikum-dresden.de $u Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany. holger.erb@uniklinikum-dresden.de $1 https://orcid.org/0000000152097914
773    0_
$w MED00002664 $t Journal of experimental & clinical cancer research : CR $x 1756-9966 $g Roč. 43, č. 1 (2024), s. 194
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39014480 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110647 $b ABA008
999    __
$a ok $b bmc $g 2202137 $s 1231701
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 43 $c 1 $d 194 $e 20240717 $i 1756-9966 $m Journal of experimental & clinical cancer research : CR $n J Exp Clin Cancer Res $x MED00002664
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace